Mid-Cavitary Obstruction in Hypertrophic Cardiomyopathy (HCM): A Rare Case Report and Management Approach
Mid-cavitary obstruction (MCO) in hypertrophic cardiomyopathy (HCM) is associated with high-risk outcomes of sudden cardiac death and heart failure.While beta-blockers can improve symptoms in many MCO patients, treatment should be personalized based on the symptom severity and risk factors.Patients with MCO are at risk of complications like apical aneurysms, thromboembolism, and arrhythmias.
Authors
- Suman Kalita
- Deb Kumar Boruah (ORCID: https://orcid.org/0000-0003-3831-135X)
- Bhupen Barman (ORCID: https://orcid.org/0000-0002-5433-1310)
- Rajeev Bharadwaj (ORCID: https://orcid.org/0000-0003-2445-4181)
Institutions
- All India Institute of Medical Sciences Guwahati (IN)
Publication Details
- Journal
- Acta medica Lituanica
- Published
- 2025-04-16
- DOI
- https://doi.org/10.15388/amed.2025.32.1.16
- Citations
- 1
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39